Track protection status across key markets to assess launch feasibility.
It is formulated by 2 pharmaceutical companies such as NODEN PHARMA, OMNIVIUM PHARMS. It is marketed under 2 brand names, including GOPRELTO, NUMBRINO. Available in 1 different strength, such as 4%, and administered through 1 route including SOLUTION;NASAL.
API availability: Loading API feasibility...
Licensing: 2 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
Strength | Route of Administration | Companies | Latest Approval Date |
---|
Patents approved by the FDA for the ingredient
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
---|---|---|---|---|---|
{"application_id":"75809","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10016407B1","cleaned_patent_number":"10016407","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2018-07-10","legal_status":"Granted"} | US10016407B2 | 10 Jul, 2018 | Granted | 07 Feb, 2037 | |
{"application_id":"75811","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10149843B1","cleaned_patent_number":"10149843","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2018-12-11","legal_status":"Patented case"} | US10149843B2 | 11 Dec, 2018 | Patented case | 07 Feb, 2037 | |
{"application_id":"75812","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10231961B1","cleaned_patent_number":"10231961","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2019-03-19","legal_status":"Granted"} | US10231961B2 Formulation | 19 Mar, 2019 | Granted | 07 Feb, 2037 | |
{"application_id":"75813","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10413505B1","cleaned_patent_number":"10413505","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2019-09-17","legal_status":"Granted"} | US10413505B2 | 17 Sep, 2019 | Granted | 07 Feb, 2037 | |
{"application_id":"75814","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10420760B1","cleaned_patent_number":"10420760","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2019-09-24","legal_status":"Granted"} | US10420760B2 | 24 Sep, 2019 | Granted | 07 Feb, 2037 | |
{"application_id":"75815","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10857095B1","cleaned_patent_number":"10857095","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2020-12-08","legal_status":"Granted"} | US10857095B2 | 08 Dec, 2020 | Granted | 07 Feb, 2037 | |
{"application_id":"75816","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10894012B1","cleaned_patent_number":"10894012","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2021-01-19","legal_status":"Granted"} | US10894012B2 | 19 Jan, 2021 | Granted | 07 Feb, 2037 | |
{"application_id":"75817","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10933060B1","cleaned_patent_number":"10933060","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2021-03-02","legal_status":"Granted"} | US10933060B2 | 02 Mar, 2021 | Granted | 07 Feb, 2037 | |
{"application_id":"75818","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10973811B1","cleaned_patent_number":"10973811","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2021-04-13","legal_status":"Granted"} | US10973811B2 | 13 Apr, 2021 | Granted | 07 Feb, 2037 | |
{"application_id":"75819","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US10987347B1","cleaned_patent_number":"10987347","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2021-04-27","legal_status":"Granted"} | US10987347B2 | 27 Apr, 2021 | Granted | 07 Feb, 2037 | |
{"application_id":"75820","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US11040032B2","cleaned_patent_number":"11040032","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2021-06-22","legal_status":"Patented case"} | US11040032B2 Formulation | 22 Jun, 2021 | Patented case | 07 Feb, 2037 | |
{"application_id":"75810","ingredient":"COCAINE HYDROCHLORIDE","trade_name":"GOPRELTO","family_id":"0d327b24712640dbb40c","publication_number":"US9867815B1","cleaned_patent_number":"9867815","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-02-07","publication_date":"2018-01-16","legal_status":"Granted"} | US9867815B2 | 16 Jan, 2018 | Granted | 07 Feb, 2037 |
Latest clinical trials and research studies for this ingredient
NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
---|
Manufacturing Locations
Unlock access to all suppliers of Cocaine Hydrochloride
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.